Satiate Agri Ltd

The next results date for Satiate Agri is 13 November 2025.

Satiate Agri Ltd, a micro-cap company in the pharmaceuticals and biotechnology sector, focuses on pharmaceutical chemicals and reported net sales of 1 Cr and a net loss of 10 Cr for the quarter ending March 2025. The company has a market cap of INR 11 Cr and no debt or dividends.

The top shareholders of Satiate Agri include Shaba Securities & Finn Services Pvt. Ltd. with 33.57%, while individual investors hold 37.97%. There are no mutual funds, foreign institutional investors, or significant public shareholders involved.

As of July 11, 2023, Satiate Agri's trend is neutral, with the price at a 52-week high of 24.03 but lacking sufficient technical indicators for a clear bullish or bearish signal.

As of July 11, 2023, Satiate Agri's trend is neutral, with the price at a 52-week high of 24.03 but lacking sufficient technical indicators for a clear bullish or bearish signal.

As of March 2022, the management team of Satiate Agri includes Indra Kumar Mahajan, Kaushik Bhai Hirpara, Pushpaben Patel (Independent Directors), Falguni Malay Patel (Company Secretary & Compliance Officer), Utpal Dineshbhai Raval (Managing Director), and Hargovind Sutariya (Executive Director). The team emphasizes governance and compliance.

As of 05-Jun, Satiate Agri Ltd is priced at Rs 22.89 with no change, outperforming its sector by 4.77% today and reaching a new 52-week high. Despite its strong short-term trend, the stock has been flat over the past week and month, lagging behind broader market performance.